Press Release – New York, NY November 9, 2022 – Sichenzia Ross Ference LLP announced today that it represented Murphy Canyon Acquisition Corp. (Nasdaq: MURF), a publicly traded special purpose acquisition company (SPAC) in a definitive merger agreement with Conduit Pharmaceuticals Limited (“Conduit”). The combined company is anticipated to have an implied initial enterprise value of approximately $700.49 million, and the transaction is expected to deliver cash proceeds of around $149.36 million to Conduit (assuming no redemptions). The combined company’s common stock is anticipated to be listed on Nasdaq under the ticker symbol “CDT”, which is expected to occur in the first quarter of 2023.
The Sichenzia Ross Ference LLP team was led by partners Darrin Ocasio, Arthur Marcus, Avital Perlman, associate Michael Blane, and law clerk Anastasia Hayes.
- Sichenzia Ross Ference Carmel LLP Represents Dominari Securities, Revere Securities and Pacific Century Securities in $6 Million Initial Public Offering of BUUU Group Limited - August 15, 2025
- Sichenzia Ross Ference Carmel LLP Represents RBW Capital Partners in $11.225 Million Private Placement of Digital Brands Group - August 15, 2025
- Sichenzia Ross Ference Carmel LLP Represents Laidlaw & Company and Craft Capital Management in $10 Million Initial Public Offering of Nasus Pharma - August 14, 2025